Latest News


17 June 2013

Genexine appoints Intralink to drive development of business in Japan

Seoul, South Korea — Korean biotech company Genexine, which specialises in new generation therapeutic vaccine technologies, has appointed Intralink to drive the development of its business in Japan.



© Intralink Limited - Registered in England. 2438141 - UK VAT No. 570 8427 29